thanks Itsa - I wasn't intending to have a go at you. I found...

thanks Itsa - I wasn't intending to have a go at you. I found your post -

Capricor: their 12 month data on PUL2 (+1.8) is no better than their 6 month data.Atl1102 had a +2.9 vs the natural history control at 6 months which presented at the last WMS. They have no myoset or MRI data.There other observations aren’t worth much. They have a safety issue with the need to pre-dose with an antihistamine.They are requiring a partner to fund to their pivotal study in DMD, focussing their resources on Covid.Sankaido: I hope that helps .. No comparison to AnpOriginally posted by sankaido: ↑

The big things that have changed are that they have got their partner and their funding (and trials underway I think)
You commented that they have a safety issue with the need to pre-dose with an antihistamine - try as I may I have not got a useful understanding of the science behind either their product and ours - Would you be able to get an opinion that aspect from one of your contacts ?



Perhaps Wayne

.